Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Maine.
Press releases published on June 30, 2025

From Trauma to Intuition: Stephanie Harmon’s Journey Featured in #1 International Best Seller, 'Whispers of the Soul'
The Wounded Little Girl Attracts the Wounded Little Boy— a Chapter from Stephanie Harmon in the International #1 Bestselling Book, “Whispers of the Soul” SCARBOROUGH, ME, UNITED STATES, June 30, 2025 /EINPresswire.com/ -- Stephanie Harmon, a spiritual …

The Real Jerry Maguire Meets Prof. Mike Chan of European Wellness Biomedical Group to Discuss Sports Injuries and Concussion Recovery
The man who inspired the multiple award-winning movie “Jerry Maguire” meets the pioneering stem cell scientist who is transforming regenerative medicine. Together, they may just hold the key to healing the silent epidemic of sports-related brain injuries. …

More Tests, No Insurance Needed: HNL Lab Medicine Grows Self-Pay Offerings
ALLENTOWN, Pa., June 30, 2025 (GLOBE NEWSWIRE) -- HNL Lab Medicine is redefining convenience in healthcare with the expansion of its HNL Lab Tests Direct menu, adding dozens of new self-pay tests that empower patients to take charge of their health without …

AdipoPharma Recognized at American Diabetes Association 85th Annual Meeting for PATAS, Its First-in-Class Whole-Body Insulin-Sensitizing Compound
CHICAGO, June 30, 2025 (GLOBE NEWSWIRE) -- AdipoPharma, a biotech company headquartered in France with offices in the U.S. and Belgium, was recognized at the American Diabetes Association’s 85th Annual Meeting this week in Chicago for its novel and …

NADP Reports Dental Benefits Market on Road to Recovery
DALLAS, June 30, 2025 (GLOBE NEWSWIRE) -- The health of the dental benefits industry showed visible signs of recovery at year-end 2023, following market disruptions resulting from the global COVID-19 pandemic. The 2024 State of the Dental Benefits Market …

Baylor Genetics’ Chairman and CEO Kengo Takishima Named One of Houston Business Journal’s 2025 Most Admired CEOs
HOUSTON, June 30, 2025 (GLOBE NEWSWIRE) -- Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing, today announced that Chairman and CEO Kengo Takishima has been named one of the 2025 Most Admired CEOs by the Houston Business …

Invasive Aspergillosis Market Forecast Reveals Opportunities in Antifungal Therapies and Diagnostics | DelveInsight
New York, USA, June 30, 2025 (GLOBE NEWSWIRE) -- Invasive Aspergillosis Market Forecast Reveals Opportunities in Antifungal Therapies and Diagnostics | DelveInsight The invasive aspergillosis market is experiencing steady growth due to the rising …

Penn Highlands Healthcare Offers July 4th/Summer Safety Tips
DuBois, Pennsylvania, June 30, 2025 (GLOBE NEWSWIRE) -- July 4th is our nation’s birthday – a time for parades, picnics, pools and the popping sounds of colorful fireworks in the evening. You can keep yourself and your family safe and healthy this holiday …

Zyter|TruCare 25.1 Adds Agentic AI, Mobile Flexibility, and Built-In Regulatory Support for Health Plans and Managed Care Organizations
Rockville, Maryland, June 30, 2025 (GLOBE NEWSWIRE) -- Zyter|TruCare, a provider of the most widely used population health management technology and services for health plans and managed care organizations, today announced the latest release of its TruCare …

OSE Immunotherapeutics Publishes Letter to Shareholders
OSE Immunotherapeutics Publishes Letter to Shareholders NANTES, France, June 30, 2025, 6:00 p.m. - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), announces the publication of its inaugural Letter to Shareholders. The Company’s CEO and Board of …

OSE Immunotherapeutics publie une Lettre aux Actionnaires
OSE Immunotherapeutics publie une Lettre aux Actionnaires NANTES, France, 30 juin 2025, 18 heures – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), annonce la publication de sa première Lettre aux Actionnaires. Le Directeur général et le …

Erdem Hospital Launches New Pre-Surgery Education Program for Bariatric Patients
Photo: Erdem Hospital via FL Communications ISTANBUL, June 30, 2025 (GLOBE NEWSWIRE) -- Erdem Hospital in Istanbul has announced the launch of a new pre-operative education program tailored specifically for bariatric patients. This initiative marks another …

Portal Biotech Raises $35 Million Series A, Leveraging AI to Deliver the World’s First Full-Length Single-Molecule Protein Sequencer
LONDON, June 30, 2025 (GLOBE NEWSWIRE) -- Portal Biotech, a pioneering biotechnology company headquartered in London, today announced a $35 million Series A raise, representing one of Europe's largest investments into a life sciences tools company. This …

Mineralys Therapeutics Announces Journal of the American Medical Association (JAMA) Publication of Pivotal Phase 3 Launch-HTN Trial for Lorundrostat
– The Launch-HTN trial is the largest trial of an aldosterone synthase inhibitor completed in participants with uncontrolled or treatment resistant hypertension – – Lorundrostat 50 mg once daily demonstrated clinically meaningful reductions in systolic …

Total number of shares and voting rights in Zealand Pharma as of June 30, 2025
Company announcement – No. 16 / 2025 Total number of shares and voting rights in Zealand Pharma as of June 30, 2025 Copenhagen, Denmark, June 30, 2025 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a …

Acentra Health Earns Fourth Consecutive Recognition on the Washington Business Journal’s Annual ‘Largest Private Companies’ List
MCLEAN, Va., June 30, 2025 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions and services company dedicated to accelerating better outcomes for its government and commercial healthcare clients and the populations they serve, has earned …

Aclaris Therapeutics Added to the Russell 2000® and Russell 3000® Indexes
WAYNE, Pa., June 30, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that the Company has been …

Clearmind Medicine Announces First Participant Ever Dosed with its CMND-100 Treatment in Groundbreaking Clinical Trial for Alcohol Use Disorder
Vancouver, Canada, June 30, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to …

Senti Bio Participates in Nasdaq Amplify Spotlight Series
Access the segment here SOUTH SAN FRANCISCO, Calif., June 30, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio” or the “Company”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using …

Joint Commission Launches a Transformative Approach to Healthcare Accreditation
OAKBROOK TERRACE, Illinois, June 30, 2025 (GLOBE NEWSWIRE) -- Joint Commission today launched Accreditation 360: The New Standard, a transformational approach to hospital and healthcare accreditation and certification. Leveraging data analytics with a …